These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1569180)

  • 1. Cysteamine enhances the procoagulant activity of Factor VIII-East Hartford, a dysfunctional protein due to a light chain thrombin cleavage site mutation (arginine-1689 to cysteine).
    Aly AM; Arai M; Hoyer LW
    J Clin Invest; 1992 May; 89(5):1375-81. PubMed ID: 1569180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII-East Hartford (arginine 1689 to cysteine) has procoagulant activity when separated from von Willebrand factor.
    Aly AM; Hoyer LW
    J Clin Invest; 1992 May; 89(5):1382-7. PubMed ID: 1569181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII molecule.
    Shima M; Ware J; Yoshioka A; Fukui H; Fulcher CA
    Blood; 1989 Oct; 74(5):1612-7. PubMed ID: 2506948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a thrombin cleavage site mutation (Arg 1689 to Cys) in the factor VIII gene of two unrelated patients with cross-reacting material-positive hemophilia A.
    Arai M; Higuchi M; Antonarakis SE; Kazazian HH; Phillips JA; Janco RL; Hoyer LW
    Blood; 1990 Jan; 75(2):384-9. PubMed ID: 2104766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of factor VIII 372-Cys: a hypofunctional cofactor from a patient with moderately severe hemophilia A.
    O'Brien DP; Pattinson JK; Tuddenham EG
    Blood; 1990 Apr; 75(8):1664-72. PubMed ID: 2109644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
    Johnson DJ; Pemberton S; Acquila M; Mori PG; Tuddenham EG; O'Brien DP
    Thromb Haemost; 1994 Apr; 71(4):428-33. PubMed ID: 8052958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal factor VIII Hiroshima: defect in crucial proteolytic cleavage by thrombin at Arg1689 detected by a novel ELISA.
    Kamisue S; Shima M; Nishimura T; Tanaka I; Nakai H; Morichika S; Takata N; Kuramoto A; Yoshioka A
    Br J Haematol; 1994 Jan; 86(1):106-11. PubMed ID: 8011517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
    Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M
    Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X.
    Yada K; Nogami K; Wakabayashi H; Fay PJ; Shima M
    Thromb Haemost; 2013 Jun; 109(6):1007-15. PubMed ID: 23467620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).
    Arai M; Inaba H; Higuchi M; Antonarakis SE; Kazazian HH; Fujimaki M; Hoyer LW
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4277-81. PubMed ID: 2498882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo.
    Pipe SW; Eickhorst AN; McKinley SH; Saenko EL; Kaufman RJ
    Blood; 1999 Jan; 93(1):176-83. PubMed ID: 9864159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
    Switzer ME; McKee PA
    J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin potentiation of factor VIII procoagulant activity: assessment by the two-stage assay.
    Kopitsky RG; Switzer ME; McKee PA
    Thromb Haemost; 1982 Apr; 47(2):145-9. PubMed ID: 6213066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays.
    Radtke KP; Griffin JH; Riceberg J; Gale AJ
    J Thromb Haemost; 2007 Jan; 5(1):102-8. PubMed ID: 17059431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
    Hill-Eubanks DC; Parker CG; Lollar P
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic Region Residues 1680-1684 in the A3 Domain of Factor VIII Contain a Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg1689.
    Nakajima Y; Minami H; Nogami K
    Thromb Haemost; 2021 Oct; 121(10):1274-1288. PubMed ID: 33592631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin G, a leukocyte protease, activates coagulation factor VIII.
    Gale AJ; Rozenshteyn D
    Thromb Haemost; 2008 Jan; 99(1):44-51. PubMed ID: 18217133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain.
    Foster PA; Fulcher CA; Houghten RA; de Graaf Mahoney S; Zimmerman TS
    J Clin Invest; 1988 Jul; 82(1):123-8. PubMed ID: 2839543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
    Pittman DD; Millenson M; Marquette K; Bauer K; Kaufman RJ
    Blood; 1992 Jan; 79(2):389-97. PubMed ID: 1730084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.